Free Access
Med Sci (Paris)
Volume 28, Number 12, Décembre 2012
Page(s) 1035 - 1037
Section Nouvelles
Published online 21 December 2012
  1. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BN. Psoriasis. N Engl J Med 2009 ; 361 : 1190–1199. [CrossRef] [Google Scholar]
  2. Li YY, Zollner TM, Schoen MP. Targeting leukocyte recruitment in the treatment of psoriasis. Clin Dermatol 2008 ; 26 : 527–538. [CrossRef] [PubMed] [Google Scholar]
  3. Gottlieb AB, Leonardi C, Kerdel F, et al. Efficacy and safety of briakinumab vs ethanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol 2011 ; 165 : 652–660. [CrossRef] [PubMed] [Google Scholar]
  4. Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009 ; 129 : 1339–1350. [CrossRef] [PubMed] [Google Scholar]
  5. Van der Fits L, Mourits S, Voerman JS, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the Il-23/IL-17 axis. J Immunol 2009 ; 182 : 5836–5845. [CrossRef] [PubMed] [Google Scholar]
  6. Papp KA, Leonardi C, Menter A, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012 ; 366 : 1181–1189. [CrossRef] [PubMed] [Google Scholar]
  7. Leonardi C, Matheson R, Zachariae C, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012 ; 366 : 1190–1199. [CrossRef] [PubMed] [Google Scholar]
  8. Hueber W, Patel DD, Dryja T, et al. Effects of AIN457, a fully human antibody to IL-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010 ; 2 : 52ra72. [CrossRef] [PubMed] [Google Scholar]
  9. Eyerich S, Eyerich K, Pennino D, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009 ; 119 : 3573–3585. [PubMed] [Google Scholar]
  10. Yssel H, Bensussan A. Existe-t-il dans la peau une nouvelle population lymphocytaire Th22 distincte des lymphocytes Th17 ? Med Sci (Paris) 2010 ; 26 : 12–4. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.